Cardlytics Historical Balance Sheet
CDLX Stock | USD 3.97 0.03 0.76% |
Trend analysis of Cardlytics balance sheet accounts such as Short Long Term Debt Total of 140.6 M, Other Current Liabilities of 125.5 M or Total Current Liabilities of 135.4 M provides information on Cardlytics' total assets, liabilities, and equity, which is the actual value of Cardlytics to its prevalent stockholders. By breaking down trends over time using Cardlytics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Cardlytics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cardlytics is a good buy for the upcoming year.
Cardlytics Inventory |
|
Cardlytics |
About Cardlytics Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Cardlytics at a specified time, usually calculated after every quarter, six months, or one year. Cardlytics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cardlytics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cardlytics currently owns. An asset can also be divided into two categories, current and non-current.
Cardlytics Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Cardlytics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cardlytics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Cardlytics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Cardlytics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Long Term Debt
Long-term debt is a debt that Cardlytics has held for over one year. Long-term debt appears on Cardlytics balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Cardlytics balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.Most accounts from Cardlytics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Cardlytics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.At this time, Cardlytics' Net Tangible Assets are fairly stable compared to the past year. Property Plant And Equipment Net is likely to rise to about 14.5 M in 2024, whereas Total Assets are likely to drop slightly above 440 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 197.2M | 235.3M | 266.1M | 140.6M | Total Assets | 1.3B | 691.2M | 574.1M | 440.0M |
Cardlytics balance sheet Correlations
Click cells to compare fundamentals
Cardlytics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cardlytics balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 224.3M | 422.5M | 1.3B | 691.2M | 574.1M | 440.0M | |
Short Long Term Debt Total | 37K | 188.1M | 197.2M | 235.3M | 266.1M | 140.6M | |
Other Current Liab | 76.0M | 70.1M | 313.4M | 238.5M | 162.2M | 125.5M | |
Total Current Liabilities | 78.4M | 81.3M | 327.4M | 248.9M | 171.1M | 135.4M | |
Total Stockholder Equity | 143.3M | 157.2M | 690.7M | 211.6M | 134.8M | 98.0M | |
Other Liab | 2.6M | 679K | 54.5M | 334K | 384.1K | 364.9K | |
Net Tangible Assets | 139.1M | 150.4M | (190.5M) | 158.1M | 181.8M | 190.9M | |
Property Plant And Equipment Net | 14.3M | 24.6M | 21.5M | 12.5M | 10.6M | 14.5M | |
Current Deferred Revenue | 1.1M | 349K | 3.3M | 1.8M | 2.4M | 1.3M | |
Net Debt | (104.4M) | (105.1M) | (36.2M) | 113.4M | 174.3M | 183.0M | |
Retained Earnings | (338.6M) | (394.1M) | (522.6M) | (976.6M) | (1.1B) | (1.1B) | |
Accounts Payable | 1.2M | 1.4M | 4.6M | 3.8M | 4.4M | 3.2M | |
Cash | 104.5M | 293.2M | 233.5M | 121.9M | 91.8M | 116.8M | |
Non Current Assets Total | 28.6M | 36.9M | 905.1M | 441.2M | 350.2M | 226.1M | |
Non Currrent Assets Other | 10.1M | 5.6M | 2.4M | 2.6M | 2.7M | 2.6M | |
Other Assets | 10.1M | 22.6M | 2.4M | 2.6M | 2.3M | 2.2M | |
Long Term Debt | 13K | 174.0M | 184.4M | 226.0M | 257.6M | 130.8M | |
Cash And Short Term Investments | 104.5M | 293.2M | 233.5M | 121.9M | 91.8M | 116.8M | |
Net Receivables | 85.4M | 86.6M | 117.2M | 120.1M | 126.0M | 89.2M | |
Common Stock Shares Outstanding | 23.7M | 27.2M | 32.2M | 33.4M | 36.5M | 26.9M | |
Long Term Debt Total | 13K | 174.0M | 184.4M | 226.0M | 260.0M | 273.0M | |
Liabilities And Stockholders Equity | 224.3M | 422.5M | 1.3B | 691.2M | 574.1M | 440.0M | |
Non Current Liabilities Total | 2.6M | 184.1M | 245.7M | 230.7M | 268.2M | 206.5M | |
Capital Surpluse | 480.6M | 551.4M | 1.2B | 1.2B | 1.4B | 1.4B | |
Inventory | 129K | 110K | 95K | 80K | 72K | 68.4K | |
Other Current Assets | 5.8M | 5.8M | 8.1M | 8.1M | 6.1M | 5.2M | |
Other Stockholder Equity | 480.6M | 551.4M | 1.2B | 1.2B | 1.2B | 628.4M | |
Total Liab | 81.0M | 265.3M | 573.1M | 479.6M | 439.3M | 342.0M | |
Deferred Long Term Liab | 8.5M | 3.8M | 139K | 198K | 178.2K | 169.3K | |
Property Plant And Equipment Gross | 14.3M | 24.6M | 11.3M | 5.9M | 43.7M | 45.9M | |
Total Current Assets | 195.7M | 385.6M | 358.7M | 250.0M | 223.9M | 213.8M | |
Accumulated Other Comprehensive Income | 1.3M | (192K) | 486K | 5.6M | 2.5M | 1.9M | |
Short Term Debt | 24K | 9.5M | 6.1M | 4.9M | 2.1M | 4.0M | |
Intangible Assets | 4.2M | 6.7M | 138.7M | 73.4M | 59.6M | 35.1M | |
Property Plant Equipment | 14.3M | 13.9M | 21.5M | 5.9M | 6.8M | 12.5M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cardlytics Stock Analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.